NASDAQ · Healthcare · Biotechnology
Roivant Sciences Ltd.
ROIV
Roivant Sciences Ltd. CEO Matthew Gline · Market cap $26.3B.
$36.36
+0.06 · +0.17%
52w hi $37.9752w lo $11.60
Off 52w high 11.2%
40
ROUTINE
Current InsiderScore
Corp · 90d
24
0 buys · 24 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $37.17
Section 01
Recent Form 4 filings
115 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 21 | Mayukh Sukhatme | President & CIO | Sell | 144,756 | $36.48 | −$5.28M | 31 |
| Aug 19 | Mayukh Sukhatme | President & CIO | Sell | 172,899 | $37.17 | −$6.43M | 31 |
| Aug 18 | Mayukh Sukhatme | President & CIO | Sell | 31,801 | $37.18 | −$1.18M | 28 |
| Aug 18 | Mayukh Sukhatme | President & CIO | Sell | 105,141 | $36.59 | −$3.85M | 28 |
| Aug 17 | Mayukh Sukhatme | President & CIO | Sell | 284,707 | $36.25 | −$10.32M | 31 |
| Aug 14 | Mayukh Sukhatme | President & CIO | Sell | 243,177 | $36.23 | −$8.81M | 31 |
| Jul 27 | Eric Venker | President & Immunovant CEO | Sell | 200,000 | $34.95 | −$6.99M | 40 |
| Jun 30 | Keith S Manchester | Sell | 200,000 | $35.45 | −$7.09M | 31 | |
| Jun 29 | QVT Financial LP | Sell | 200,000 | $34.44 | −$6.89M | 22 | |
| Jun 29 | Daniel Allen Gold | Sell | 200,000 | $34.44 | −$6.89M | 25 | |
| Jun 29 | Daniel Allen Gold | Sell | 600,000 | $34.59 | −$20.75M | 25 | |
| Jun 29 | Keith S Manchester | Sell | 200,000 | $34.44 | −$6.89M | 25 | |
| Jun 29 | Keith S Manchester | Sell | 600,000 | $34.59 | −$20.75M | 25 | |
| Jun 29 | QVT Financial LP | Sell | 600,000 | $34.59 | −$20.75M | 22 | |
| Jun 26 | Mayukh Sukhatme | President & CIO | Sell | 500,000 | $34.08 | −$17.04M | 31 |
| Jun 26 | QVT Financial LP | Sell | 325,000 | $34.07 | −$11.07M | 22 | |
| Jun 26 | Daniel Allen Gold | Sell | 300,783 | $33.92 | −$10.20M | 25 | |
| Jun 26 | Daniel Allen Gold | Sell | 325,000 | $34.07 | −$11.07M | 25 | |
| Jun 26 | Keith S Manchester | Sell | 300,783 | $33.92 | −$10.20M | 25 | |
| Jun 26 | Keith S Manchester | Sell | 325,000 | $34.07 | −$11.07M | 25 | |
| Jun 26 | QVT Financial LP | Sell | 300,783 | $33.92 | −$10.20M | 22 | |
| Jun 25 | Mayukh Sukhatme | President & CIO | Sell | 500,000 | $34.13 | −$17.07M | 31 |
| Jun 24 | Eric Venker | President & Immunovant CEO | Sell | 153,766 | $33.05 | −$5.08M | 37 |
| Jun 24 | Eric Venker | President & Immunovant CEO | Sell | 46,234 | $33.51 | −$1.55M | 31 |
| May 22 | Eric Venker | President & Immunovant CEO | Sell | 200,000 | $30.27 | −$6.05M | 48 |
| Apr 20 | Eric Venker | President & Immunovant CEO | Sell | 200,000 | $29.59 | −$5.92M | 40 |
| Apr 16 | Matthew Gline | CEO | Sell | 289,774 | $29.16 | −$8.45M | 34 |
| Mar 26 | Meghan Fitzgerald | Sell | 70,000 | $27.45 | −$1.92M | 35 | |
| Mar 17 | Eric Venker | President & Immunovant CEO | Sell | 200,000 | $28.24 | −$5.65M | 40 |
| Mar 16 | Melissa B, Epperly | Sell | 41,861 | $28.68 | −$1.20M | 35 | |
| Feb 23 | Frank Torti | President and Vant Chair | Sell | 587,390 | $27.51 | −$16.16M | 31 |
| Feb 20 | Frank Torti | President and Vant Chair | Sell | 1,012,610 | $27.15 | −$27.49M | 34 |
| Feb 19 | Frank Torti | President and Vant Chair | Sell | 1,400,000 | $27.42 | −$38.39M | 34 |
| Feb 13 | QVT Financial LP | Sell | 150,784 | $26.49 | −$3.99M | 19 | |
| Feb 13 | Daniel Allen Gold | Sell | 150,784 | $26.49 | −$3.99M | 22 | |
| Feb 13 | Daniel Allen Gold | Sell | 225,000 | $26.50 | −$5.96M | 25 | |
| Feb 13 | Keith S Manchester | Sell | 150,784 | $26.49 | −$3.99M | 22 | |
| Feb 13 | Keith S Manchester | Sell | 225,000 | $26.50 | −$5.96M | 25 | |
| Feb 13 | QVT Financial LP | Sell | 225,000 | $26.50 | −$5.96M | 22 | |
| Feb 13 | Eric Venker | President & Immunovant CEO | Sell | 200,000 | $26.49 | −$5.30M | 40 |
| Feb 12 | Daniel Allen Gold | Sell | 150,000 | $26.72 | −$4.01M | 22 | |
| Feb 12 | Daniel Allen Gold | Sell | 275,000 | $26.76 | −$7.36M | 25 | |
| Feb 12 | Keith S Manchester | Sell | 150,000 | $26.72 | −$4.01M | 22 | |
| Feb 12 | Keith S Manchester | Sell | 275,000 | $26.76 | −$7.36M | 25 | |
| Feb 12 | QVT Financial LP | Sell | 275,000 | $26.76 | −$7.36M | 22 | |
| Feb 12 | QVT Financial LP | Sell | 150,000 | $26.72 | −$4.01M | 19 | |
| Feb 11 | Daniel Allen Gold | Sell | 425,000 | $26.67 | −$11.33M | 25 | |
| Feb 11 | Keith S Manchester | Sell | 425,000 | $26.67 | −$11.33M | 25 | |
| Feb 11 | QVT Financial LP | Sell | 425,000 | $26.67 | −$11.33M | 22 | |
| Feb 09 | Mayukh Sukhatme | President & CIO | Sell | 339,441 | $26.47 | −$8.99M | 31 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug